Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-25-022834
Filing Date
2025-07-16
Accepted
2025-07-16 16:12:18
Documents
21
Period of Report
2025-08-15

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A gnpx20250707_def14a.htm   iXBRL DEF 14A 1288759
6 gen1.jpg GRAPHIC 7071
7 image1.jpg GRAPHIC 239499
8 image2.jpg GRAPHIC 202416
9 proxy_netloss2025800px.jpg GRAPHIC 72981
10 proxy_tsr2025800px.jpg GRAPHIC 74393
11 ryanconfersignew.jpg GRAPHIC 16173
  Complete submission text file 0001437749-25-022834.txt   3273683

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20241231.xsd EX-101.SCH 4569
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20241231_def.xml EX-101.DEF 1750
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20241231_lab.xml EX-101.LAB 1775
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20241231_pre.xml EX-101.PRE 714
23 EXTRACTED XBRL INSTANCE DOCUMENT gnpx20250707_def14a_htm.xml XML 5671
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38244 | Film No.: 251127593
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)